Tvardi Therapeutics, Inc.
SEC CIK 1346830 · TVRD · last insider filing 2026-06-11
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Wyzga Michael S | Director | filed 2025–2026 |
| Shah Sujal | Director | filed 2025–2026 |
| Smith Cynthia | Director | filed 2025–2026 |
| Hall Wallace L JR | Director | filed 2025–2026 |
| Shiff Susan Ph.D. | Director | filed 2020–2026 |
| Alibhai Imran Nizamudin | Director · Chief Executive Officer | filed 2025–2026 |
| Wirk Shaheen | Director | filed 2025–2025 |
| Posner Christopher | Director · President and CEO | filed 2018–2025 |
| Vogelbaum Martin | Director | filed 2014–2024 |
| Ives Jeffrey L. | Director | filed 2014–2024 |
| Boudreau Helen M | Director | filed 2023–2024 |
| von Moltke Lisa | Director | filed 2022–2024 |
| Bains Harrison M JR | Director | filed 2014–2023 |
| Chalmers Derek T | Director · President & CEO | filed 2014–2021 |
| Slagel Dean | Director | filed 2014–2017 |
| Hurwitz Edward | Director | filed 2014–2014 |
| Moller Charles Ph.D. | Director | filed 2014–2014 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Kauh John Saewook M.D. | Chief Medical Officer | filed 2025–2026 |
| O'Brien Stephen Paul | Principal Accounting Officer | filed 2025–2026 |
| Conn Avi Daniel | Chief Financial Officer | filed 2025–2026 |
| Larson Jeffrey Leroy | SVP, Research & Development | filed 2025–2025 |
| Chen Yixin | VP, Chem, Mfg and Ctrls | filed 2025–2025 |
| Terrillion Scott | Sec'y; Chief Compliance & G.C. | filed 2017–2025 |
| Goncalves Joana | Chief Medical Officer | filed 2018–2024 |
| Maynard Ryan D | Chief Financial Officer | filed 2022–2024 |
| Menzaghi Frederique Ph.D. | VP-Research & Development | filed 2014–2024 |
| Makara Richard | VP, Head of Accting;Controller | filed 2019–2022 |
| Reilly Thomas Charles | Chief Financial Officer | filed 2020–2022 |
| Mohindru Mani | CFO & Chief Strategy Officer | filed 2017–2019 |
| Stauffer Joseph William | Chief Medical Officer | filed 2014–2018 |
| Schoell Josef | Chief Financial Officer | filed 2014–2017 |
| Lewis Michael E | Chief Scientific Advisor | filed 2014–2017 |
| Medve Robert | Chief Medical Officer | filed 2014–2014 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.